<DOC>
	<DOCNO>NCT00631319</DOCNO>
	<brief_summary>To evaluate efficacy OROS Hydromorphone reduce moderate severe chronic pain patient Osteoarthritis ( OA ) Pain</brief_summary>
	<brief_title>A Double-blind Study Controlled Release OROS Hydromorphone Compared Placebo Patients With Chronic OA Pain</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Hydromorphone</mesh_term>
	<criteria>Primary clinic diagnosis OA pain hip knee least 6 month Patients require daily opioid medication treat chronic OA pain Joint replacement hip knee primary source OA Pain History drug alcohol abuse Fibromyalgia Patients plan joint replacement surgery within next 6 month Patients major depression anxiety Women pregnant breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>OA</keyword>
	<keyword>Chronic Pain</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>OA Pain</keyword>
	<keyword>Osteoarthritis Pain</keyword>
	<keyword>Pain</keyword>
	<keyword>Hip Pain</keyword>
	<keyword>Knee Pain</keyword>
	<keyword>Joint Pain</keyword>
</DOC>